These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 4143953)

  • 1. Parkinson's disease: from brain homogenate to treatment.
    Hornykiewicz O
    Fed Proc; 1973 Feb; 32(2):183-90. PubMed ID: 4143953
    [No Abstract]   [Full Text] [Related]  

  • 2. [Biochemical bases of Parkinson disease].
    Colucci d'Amato C; Puccini A; Cristillo A; Vizioli R
    Recenti Prog Med; 1984 Oct; 75(10):889-901. PubMed ID: 6151219
    [No Abstract]   [Full Text] [Related]  

  • 3. [The role of dopamine in the physiology and pathology of the basal ganglia].
    Arushanian EB
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1972; 72(4):595-603. PubMed ID: 4341763
    [No Abstract]   [Full Text] [Related]  

  • 4. Proceedings: Para-o-methylation of dopamine in human brain.
    Ebinger G; Verheyden R
    Acta Neurol Belg; 1975; 75(2):111. PubMed ID: 1155020
    [No Abstract]   [Full Text] [Related]  

  • 5. [Abnormalities of catecholamine metabolism in Parkinson's disease (author's transl)].
    Nagatsu T
    Tanpakushitsu Kakusan Koso; 1981 Aug; 26(11):1781-8. PubMed ID: 6117927
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of chronically administered L-dopa in normal and lesioned cats.
    Langelier P; Roberge AG; Boucher R; Poirier LJ
    J Pharmacol Exp Ther; 1973 Oct; 187(1):15-26. PubMed ID: 4746324
    [No Abstract]   [Full Text] [Related]  

  • 7. [Dopaminergic conception of Parkinsonism and its treatment with L-DOPA].
    Levin SL
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1972; 72(9):1418-26. PubMed ID: 4349303
    [No Abstract]   [Full Text] [Related]  

  • 8. Metabolic interactions of pyridoxine, levodopa, and carbidopa in Parkinson's disease.
    Mars H
    Trans Am Neurol Assoc; 1973; 98():241-5. PubMed ID: 4784941
    [No Abstract]   [Full Text] [Related]  

  • 9. Dopaminergic nervous transmission in Parkinson's disease.
    Rinne UK; Sonninen V; Riekkinen P; Laaksonen H
    Med Biol; 1974 Jun; 52(3):208-17. PubMed ID: 4371255
    [No Abstract]   [Full Text] [Related]  

  • 10. The neurochemistry of Parkinson's disease: effect of L-dopa therapy.
    Lloyd KG; Davidson L; Hornykiewicz O
    J Pharmacol Exp Ther; 1975 Dec; 195(3):453-64. PubMed ID: 489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Neurochemical aspects of parkinsonism. Review of the literature].
    De Mattos JP; Cechela C; Adams JG; De Lima JM
    Arq Neuropsiquiatr; 1982 Sep; 40(3):289-95. PubMed ID: 6130754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-induced changes in brain dopamine and their relation to parkinsonism.
    Vogt M
    Sci Basis Med Annu Rev; 1970; ():276-91. PubMed ID: 4319923
    [No Abstract]   [Full Text] [Related]  

  • 13. [Disturbances of monoamine metabolism in organic presenile and senile dementia].
    Gottfries CG
    Lakartidningen; 1974 Mar; 71(13):1284-5. PubMed ID: 4823610
    [No Abstract]   [Full Text] [Related]  

  • 14. L-dopa therapy in parkinsonism: mechanism of action.
    Sandler M
    Psychiatr Neurol Neurochir; 1971; 74(4):331-3. PubMed ID: 5146239
    [No Abstract]   [Full Text] [Related]  

  • 15. Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations.
    Bernheimer H; Birkmayer W; Hornykiewicz O; Jellinger K; Seitelberger F
    J Neurol Sci; 1973 Dec; 20(4):415-55. PubMed ID: 4272516
    [No Abstract]   [Full Text] [Related]  

  • 16. Nucleus ruber and L-dopa psychosis: biochemical post-mortem findings.
    Birkmayer W; Danielczyk W; Neumayer E; Riederer P
    J Neural Transm; 1974; 35(2):93-116. PubMed ID: 4844103
    [No Abstract]   [Full Text] [Related]  

  • 17. The metabolism of brain dopamine in human parkinsonism.
    Hornykiewicz O
    Riv Patol Nerv Ment; 1970 Oct; 91(5):281-6. PubMed ID: 5525774
    [No Abstract]   [Full Text] [Related]  

  • 18. Dopaminergic responses to striatal damage.
    Howells DW; Liberatore GT; Wong JY; Donnan GA
    J Neurol Sci; 1996 Jul; 139(1):125-30. PubMed ID: 8836983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for descending pallido-nigral GABA-containing neurons.
    McGeer PL; Fibiger HC; Maler L; Hattori T; McGeer EG
    Adv Neurol; 1974; 5():153-60. PubMed ID: 4155231
    [No Abstract]   [Full Text] [Related]  

  • 20. L-dopa in Parkinson's syndrome.
    Poskanzer DC
    N Engl J Med; 1969 Feb; 280(7):382-3. PubMed ID: 5764823
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.